Bio-key's Q3 2025 revenue fell due to fewer large customer orders compared to the previous year. While service revenue remained steady, declines in license fees and hardware sales impacted total results. Cost-cutting helped reduce operating expenses, but the company still posted a net loss.

Bio-key’s Q4 2024 performance reflected a 20% increase in license fee revenue and a meaningful reduction in net loss. The transition away from lower-margin services and hardware sales contributed to a substantial improvement in profitability despite a year-over-year revenue decline.

BIO-key International, Inc. reported an 18% increase in Q3 2024 revenue to $2.1 million, driven by a rise in license revenue. The company also reduced its net loss and improved its cash position.

BIO-key's Q2 2024 revenues decreased to $1.1 million from $1.9 million in Q2 2023, primarily due to delays in software license fee recognition and lower project-related services revenue. However, the company reduced its net loss to $1.7 million from $2.6 million year-over-year, driven by improved gross profit and reduced operating expenses.

BIO-key reported Q1 2024 revenues of $2.2M, which was in line with Q1 2023 and a 19.5% increase from Q4 2023. The company achieved positive cash flow from operations and reduced its net loss by 70%. Gross profit increased significantly due to a hardware reserve in Q1 2023 and a higher proportion of high-margin license fee revenue.

BIO-key International, Inc. reported preliminary Q4 2023 results, featuring a 26% revenue increase driven by hardware sales and a reduced net loss due to higher revenue and lower operating costs. The company is focused on expanding its market presence and reducing costs to achieve profitability.

BIO-key International, Inc. reported a 30% increase in Q3 revenue to $1.8 million compared to $1.4 million in Q3 2022. The company's gross profit also improved by 40% to $1.4 million, and the net loss per share was reduced by approximately 72% to ($0.08).

BIO-key International reported Q2 2023 revenues of $1.9 million, which approximated the revenue from Q2 2022. Despite flat revenue, the company reduced its net loss due to higher gross profit and lower operating costs. The company is confident in delivering significant top-line growth and bottom-line improvements for the full fiscal year 2023.

BIO-key reported record quarterly revenue for Q1 2023, with a 59% increase to $3.1 million, driven by a growing base of annual recurring software and software maintenance revenue, as well as strong new and existing customer activity. The company also reported improved bottom line results, with gross profit rising to $2.3 million and a reduced operating loss of $0.3 million.

BIO-key International, Inc. reported an 88% increase in Q4 2022 revenue to $1.76 million and a net loss of $5.1 million, or $0.62 per share. The company's FY22 revenue increased 37% to $7.0 million. They are implementing expense reduction initiatives to improve profitability in 2023.

BIO-key International, Inc. reported a 6% increase in Q3 2022 revenues, reaching $1.4 million, driven by growth in software licenses and service fees, which was partially offset by lower hardware revenue. The company experienced a net loss of $2.4 million, or $0.29 per share, compared to a net loss of $1.0 million, or $0.13 per share in Q3 2021.

BIO-key International reported a strong second quarter with a 96% increase in revenue to $1.9 million, driven by growth in software license fees, hardware, and services revenue. They are confident in achieving their full-year 2022 revenue guidance of $10-13M.

BIO-key's Q1 2022 revenue increased by 3% to $1.94 million compared to Q1 2021, driven by a 205% increase in software license fees. The company reported an operating loss of $1.0 million and a net loss of $1.0 million, or $0.12 per share.

BIO-key International, Inc. reported a decline in Q4 revenue to $935K from $1.1M in the previous year, while the operating loss increased to $2M from $1.4M. However, license fee revenue increased 52% to $544k, representing 88% of total gross profit.

BIO-key International, Inc. reported a 38% year-over-year increase in Q3 revenue, driven by growing demand for its cloud-based PortalGuard identity and access control solution and expansion of its Channel Alliance Partner program. The company is revising its full-year revenue guidance due to delays in large-scale projects in Africa.

BIO-key International, Inc. reported a significant increase in revenue and a reduced net loss for the second quarter of 2021. The company's revenue grew by 223% compared to the same period last year, driven by increased license fee revenue and the acquisition of PortalGuard. The net loss available to common stockholders was reduced to $1.2 million, or ($0.15) per share, compared to a net loss of $1.6 million, or ($0.60) per share, in Q2 2020.

BIO-key International, Inc. reported a significant increase in Q1 2021 revenue, growing to $1.8 million from $0.5 million in Q1 2020. This growth was driven by more than 100% increase in license revenue and a 1193% increase in hardware revenue, including $680k from African projects. The company's net loss decreased to $0.7 million, or ($0.09) per share, compared to a net loss of $3.5 million, or ($1.84) per share in the previous year.

BIO-key International, Inc. reported a significant increase in Q4 revenue, doubling to $1.1M compared to Q4'19, and a 25% increase in 2020 revenue, reaching $2.8M. The company ended the year with a strong cash position of $17M following a strategic recapitalization and the acquisition of PistolStar/PortalGuard. BIO-key expects full year 2021 revenues to range between $8M and $12M.

BIO-key reported a significant increase in Q3 revenue, driven by the acquisition of PortalGuard, and ended the quarter with a strong cash position due to a public offering. The company is also seeing progress in its African contracts and expects continued improvement in Q4.

BIO-key reported a decline in Q2 2020 revenues due to the COVID-19 pandemic, but gross margin improved. The company completed a recapitalization and acquired PistolStar to expand its software solutions and market reach. They anticipate revenue of $75M over 2 years from contracts in Nigeria which have been delayed due to COVID-19.

BIO-key reported a decrease in Q1 2020 revenue, but a significant improvement in gross margin and a reduction in operating loss compared to Q1 2019. The company's focus on large African contracts positions it for substantial revenue growth in 2020.